What Is the Lawful Hemp Protection Act? H.R. 9830 Explained — and What It Means for Hemp in DC, Maryland, and Virginia

What Is the Lawful Hemp Protection Act?

The Lawful Hemp Protection Act (H.R. 9830) is a bipartisan federal bill introduced on July 22, 2026, by Rep. Andy Barr (R-KY) and Rep. Angie Craig (D-MN). The bill proposes a permanent federal regulatory framework for hemp-derived products — an alternative to the outright ban scheduled to take effect under Section 781 of Public Law 119-37. If passed, H.R. 9830 would raise the legal total THC threshold from 0.3% to 1% on a dry-weight basis, require buyers to be 21 or older, place hemp consumables under FDA oversight, and mandate domestic sourcing. It is currently before four House committees and has not been signed into law.

Legal Status: What the Law Says Right Now

Federal hemp law is in flux. The 2018 Farm Bill defined hemp as cannabis with no more than 0.3% delta-9 THC on a dry-weight basis — a threshold that enabled the explosion of delta-8, THCA flower, and hemp-derived cannabinoid products that now fill shelves across the country.

That changed in November 2025. The FY2026 Agriculture Appropriations Act (Public Law 119-37) included Section 781, which tightened the definition in two ways: it moved to a total THC standard (combining delta-9 and its precursor THCA) and added a 0.4mg cap per container on finished products. Industry groups estimate that cap would eliminate roughly 95% of current hemp-derived cannabinoid products from the market. The original enforcement date was November 12, 2026.

On August 8, 2026, the Senate passed a Continuing Resolution (CR) that delays Section 781 enforcement from November 12 to December 11, 2026. That CR now heads to the House. One important note: the delay does not cover synthetic cannabinoids — products like THC-O and certain HHC variants that cannot be naturally produced by the plant. Those remain on track to become federally illegal on November 12.

H.R. 9830 is the House's proposed permanent answer to this problem. It is not a delay. It is a full legislative framework. As of early August 2026, the bill has been referred to four committees: Ways and Means, Energy and Commerce, Agriculture, and Transportation and Infrastructure. The House returns from recess on August 31, 2026.

For more background on the Section 781 ban itself, see our full explainer on the federal hemp THC ban.

Hemp in DC, Maryland, and Virginia Right Now

For consumers and businesses in the DMV, the current window remains open. Hemp-derived products that comply with the 2018 Farm Bill's 0.3% delta-9 standard are federally legal and available now at licensed retailers and delivery services across Washington DC, Maryland, and Virginia.

In DC, hemp products are available through licensed retailers and delivery services. Maryland's regulated cannabis market runs parallel to its hemp retail landscape. Virginia's hemp market is more complicated: a state budget provision effective August 15, 2026, imposes a 2mg total THC per package cap, and seven hemp businesses filed suit in federal court on July 31 seeking to block enforcement. That litigation is ongoing — no injunction has been issued as of August 8.

If you are in the DC, Maryland, or Virginia area and want compliant hemp-derived products available now, visit the Bud Lords shop for same-day delivery.

For the full picture on what the Senate passed and what comes next, see our Senate CR recap.

What H.R. 9830 Would Change: The Key Provisions

Here is what H.R. 9830 proposes — and what it would mean in practice if enacted:

1% Total THC Standard

The bill would redefine hemp to allow up to 1% total THC on a dry-weight basis, up from the current 0.3% delta-9 standard. This matters because total THC includes THCA — the acidic precursor that converts to delta-9 when heated. THCA flower often tests above 20% THCA but under 0.3% delta-9, which is why it has existed in a grey zone under current law.

Under H.R. 9830, a product must stay below 1% total THC (delta-9 plus THCA combined) to qualify as hemp. Critics note this would still disqualify most THCA flower products currently on the market, since those products regularly test well above 1% total THC.

Age 21 and Older

The bill restricts the purchase, sale, and consumption of hemp-derived consumables to adults 21 years of age and older. Retailers would be required to verify age with a government-issued photo ID at the point of sale.

FDA Oversight and Serving Limits

H.R. 9830 classifies hemp-derived cannabinoid products as food under the Federal Food, Drug, and Cosmetic Act, bringing them under FDA jurisdiction. The FDA would have 12 months to establish maximum cannabinoid serving limits.

If the FDA fails to act within that window, fallback limits would kick in automatically:

• 5mg THC per serving for ingestible products (edibles, capsules, beverages)

• 50mg THC for inhalable and topical products

Domestic Sourcing

Products sold in interstate commerce under H.R. 9830 would need to be cultivated, processed, finished, packaged, and labeled entirely within the United States. This provision targets the import of offshore hemp biomass and finished products, which some domestic producers have flagged as a quality and regulatory compliance concern.

Ban on Synthetic Cannabinoids

The bill expressly prohibits cannabinoids that are non-naturally occurring or artificially synthesized — including THC-O and certain forms of HHC. This aligns with the Section 781 synthetic ban already in effect and would not represent a new restriction for most conventional hemp products.

Federal Taxes and Distribution Structure

H.R. 9830 introduces a federal excise tax framework:

• 5 cents per milligram of THC for hemp-derived beverages

• 5% tax on retail price for other consumables

• 5% tax on annual gross sales for manufacturers

Hemp beverages would also face a three-tier distribution requirement modeled on the alcohol industry — manufacturer, wholesaler, retailer — with TTB (Alcohol and Tobacco Tax and Trade Bureau) oversight. Revenue would fund a new federal trust fund for hemp product oversight.

What Products Are Available in the DMV Market Now

The DMV hemp market has grown significantly under the current regulatory framework. Consumers in DC, Maryland, and Virginia currently have access to a wide range of hemp-derived products, including:

• THCA flower — the most debated category under both current and proposed law, since THCA converts to delta-9 when smoked

• Delta-8 THC products — gummies, vape cartridges, tinctures, and pre-rolls derived from hemp

• Hemp-derived beverages — seltzers, shots, and canned drinks with low-dose THC (typically 2–10mg per serving)

• CBD products — tinctures, capsules, topicals, and oils with no significant psychoactive effect

• Full-spectrum extracts — products containing the complete cannabinoid profile of the hemp plant, within legal thresholds

Under H.R. 9830 as proposed, most of these categories would continue to exist — but the 1% total THC cap would likely push the THCA flower segment out of the hemp market entirely. Retailers and consumers tracking the legislation should pay particular attention to that provision.

Bud Lords carries a curated selection of compliant hemp-derived products available for same-day delivery in the DC, Maryland, and Virginia area. Browse the full shop here.

What H.R. 9830 Means for the DMV Hemp Market

For hemp businesses operating in Washington DC, Maryland, and Virginia, H.R. 9830 represents both relief and new constraints.

Relief: the 0.4mg per container cap in Section 781 would be repealed. That provision was widely viewed as an effective prohibition on the entire hemp consumables market. Replacing it with a 1% total THC standard would preserve a meaningful commercial hemp sector — though a smaller one than exists today.

New constraints: the age 21+ requirement and mandatory age verification would add operational complexity for hemp retailers. The federal excise tax structure — especially for beverage producers — would raise costs. And the domestic sourcing requirement would affect businesses that currently import hemp biomass or finished products.

Virginia adds an extra layer of complexity. The state's 2mg per package cap (effective August 15, 2026) is currently being challenged in federal court by seven hemp businesses. That litigation is independent of the federal H.R. 9830 process — but if the federal bill passes with a 1% total THC standard, it would create a federal floor that may conflict with Virginia's stricter cap.

For the latest on the Virginia hemp lawsuit, see our full coverage of the 2mg cap litigation.

Thirty-five state attorneys general have also weighed in on the federal hemp debate. For that context, see our article on the AGs' opposition letter.

What Happens Next: The Legislative Path Forward

The immediate deadline is the government funding deadline: September 30, 2026. Congress must pass either a new appropriations bill or another CR before that date to avoid a government shutdown. The Senate's CR (extending funding through December 11) now goes to the House, which is currently in recess until August 31.

When the House returns, it must reconcile its version of the CR (which does not include the hemp delay) with the Senate version (which does). If the House adopts the Senate language, the Section 781 enforcement deadline moves from November 12 to December 11, giving the industry one more month.

H.R. 9830 is on a separate track. With four committee referrals, it would need to clear those committees, pass a full House floor vote, pass the Senate, and be signed by the President to become law. That process is not expected to complete before the CR deadline. But if both chambers signal support for H.R. 9830's framework during CR negotiations, it could influence how the final appropriations deal is structured.

The most likely near-term outcome: the House passes the CR with the hemp delay included, giving the industry until December 11. H.R. 9830 then becomes the vehicle for negotiating a longer-term solution during the fall appropriations cycle. Nothing is certain — but the bipartisan introduction of H.R. 9830 signals that both parties see a permanent regulatory framework as the goal, not just a series of delays.

Frequently Asked Questions

What is the Lawful Hemp Protection Act?

The Lawful Hemp Protection Act (H.R. 9830) is a bipartisan federal bill introduced July 22, 2026, by Rep. Andy Barr (R-KY) and Rep. Angie Craig (D-MN). It proposes a permanent federal regulatory framework for hemp-derived products, including a 1% total THC limit, an age 21+ requirement, FDA oversight, and domestic sourcing mandates.

What does the 1% total THC standard mean?

Under H.R. 9830, hemp would be redefined to allow up to 1% total THC on a dry-weight basis. Total THC includes both delta-9 THC and THCA. This is higher than the current 0.3% delta-9 standard, but would likely disqualify most THCA flower products, which regularly test above 1% total THC when THCA is included in the calculation.

How is H.R. 9830 different from the Senate CR hemp delay?

The Senate CR is a temporary delay: it pushes the Section 781 enforcement date from November 12 to December 11, 2026, buying the industry one more month. H.R. 9830 is a permanent alternative: it would repeal the 0.4mg per container cap and replace it with a full regulatory framework. One is a stopgap; the other is the proposed long-term solution.

Is H.R. 9830 law yet?

No. As of August 2026, H.R. 9830 has been introduced in the House and referred to four committees (Ways and Means, Energy and Commerce, Agriculture, and Transportation and Infrastructure). It has not passed any committee, has not passed a full House vote, has not passed the Senate, and has not been signed by the President. It is a proposal, not law.

What happens if neither H.R. 9830 nor the CR passes before November 12?

If no legislative action is taken before November 12, 2026, Section 781 of Public Law 119-37 would take effect. That would impose a 0.4mg per container cap on finished hemp products, which industry groups estimate would eliminate roughly 95% of current hemp-derived cannabinoid products from the market. A government shutdown scenario or political gridlock could create this outcome, though most observers expect some form of delay or deal before that date.

What does H.R. 9830 mean for hemp products in DC, Maryland, and Virginia?

For DMV consumers and businesses, H.R. 9830 would repeal the strict 0.4mg container cap and replace it with a 1% total THC standard — better than the current ban threat, but more restrictive than the 2018 Farm Bill baseline. THCA flower would likely not survive the 1% total THC test. Most other hemp-derived products (delta-8 gummies, CBD oils, low-dose hemp beverages) would likely remain viable under the proposed framework, depending on potency.

What is the Virginia hemp 2mg cap, and how does it relate to H.R. 9830?

Virginia passed a state budget provision imposing a 2mg total THC per package cap on hemp products, effective August 15, 2026. Seven hemp businesses filed a federal lawsuit on July 31 challenging the cap. H.R. 9830 is a federal bill and operates independently of Virginia's state law — but if H.R. 9830 passes with a 1% total THC standard and no per-package mg cap, it could create a federal floor that conflicts with Virginia's stricter approach. That tension would likely need to be resolved in court or through separate state legislation.

When will Congress vote on H.R. 9830?

No committee hearings or floor votes are currently scheduled for H.R. 9830. The House is in recess until August 31, 2026. When it returns, the priority is the CR and avoiding a government shutdown on September 30. H.R. 9830's provisions may influence CR negotiations, but a standalone vote on the bill is unlikely before the fall appropriations cycle.

This article was researched and written with AI assistance by the Bud Lords AI Newsroom. All legislative details, bill provisions, committee referrals, Senate CR timeline, Virginia litigation status, and source citations have been verified against official public records and primary sources as of August 8, 2026.

Sources

• Rep. Andy Barr press release — July 22, 2026: barr.house.gov

• U.S. Hemp Roundtable / Hemp Supporter — Lawful Hemp Protection Act summary

• Forbes — Bipartisan Lawmakers Introduce Hemp Regulation Bill, July 23, 2026

• Marijuana Moment — August 2026 coverage of H.R. 9830 and Senate CR hemp delay: marijuanamoment.net

• Section 781, Public Law 119-37 (FY2026 Agriculture Appropriations Act)

• Senate Continuing Resolution — Section 2019, August 2026: hemp delay November 12 to December 11, 2026

• Virginia 2mg hemp lawsuit — Western District of Virginia, Roanoke Division, filed July 31, 2026

• Last verified: August 8, 2026